N-3C01 Monotherapy and Combination With PD-(L)1 Inhibitors in Advanced Solid Tumors

Clinical trial NCT07639450 · RECRUITING

Trial details

NCT number: NCT07639450
Sponsor: Hefei Xinzhu Biological Technology Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Malignant Solid Tumors

Start date: 2026-06-15
Primary completion: 2028-08-31
Enrollment: 114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.